{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:57:10Z","timestamp":1772899030617,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Military Med Res"],"DOI":"10.1186\/s40779-024-00513-y","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T04:02:44Z","timestamp":1706760164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3875-4759","authenticated-orcid":false,"given":"Mabel L.","family":"Cummins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Delmonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skylar","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Schlesinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"513_CR1","first-page":"151","volume":"6","author":"V Chavali","year":"2013","unstructured":"Chavali V, Tyagi SC, Mishra PK. Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes. 2013;6:151\u201360.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"513_CR2","first-page":"63","volume":"10","author":"MY Jiang","year":"2023","unstructured":"Jiang MY, Man WR, Zhang XB, Zhang XH, Duan Y, Lin J, et al. Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid \u03b2-oxidation to alleviate diabetic cardiomyopathy. Mil Med Res. 2023;10(1):63.","journal-title":"Mil Med Res"},{"key":"513_CR3","doi-asserted-by":"publisher","first-page":"1227104","DOI":"10.3389\/fimmu.2023.1227104","volume":"14","author":"J Zheng","year":"2023","unstructured":"Zheng J, Ma Y, Guo X, Wu J. Immunological characterization of stroke-heart syndrome and identification of inflammatory therapeutic targets. Front Immunol. 2023;14:1227104.","journal-title":"Front Immunol"},{"issue":"1","key":"513_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsps.2020.12.003","volume":"29","author":"JZ AlTamimi","year":"2021","unstructured":"AlTamimi JZ, BinMowyna MN, AlFaris NA, Alagal RI, El-Kott AF, Al-Farga AM. Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R. Saudi Pharm J. 2021;29(1):27\u201342.","journal-title":"Saudi Pharm J"},{"issue":"7","key":"513_CR5","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3390\/ijms23073587","volume":"23","author":"K Nakamura","year":"2022","unstructured":"Nakamura K, Miyoshi T, Yoshida M, Akagi S, Saito Y, Ejiri K, et al. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. Int J Mol Sci. 2022;23(7):3587.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"513_CR6","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1053\/meta.2000.17721","volume":"49","author":"MJ Reed","year":"2000","unstructured":"Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism. 2000;49(11):1390\u20134.","journal-title":"Metabolism"},{"issue":"1","key":"513_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41598-017-18896-5","volume":"8","author":"DA Barri\u00e8re","year":"2018","unstructured":"Barri\u00e8re DA, Noll C, Roussy G, Lizotte F, Kessai A, Kirby K, et al. Combination of high-fat\/high-fructose diet and low-dose streptozotocin to model long-term type-2 diabetes complications. Sci Rep. 2018;8(1):424.","journal-title":"Sci Rep"},{"issue":"10","key":"513_CR8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41590-020-0750-1","volume":"21","author":"H Zhou","year":"2020","unstructured":"Zhou H, Wang H, Yu M, Schugar RC, Qian W, Tang F, et al. IL-1 induces mitochondrial translocation of Irak2 to suppress oxidative metabolism in adipocytes. Nat Immunol. 2020;21(10):1219\u201331.","journal-title":"Nat Immunol"},{"key":"513_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12933-015-0286-0","volume":"14","author":"NW Roberts","year":"2015","unstructured":"Roberts NW, Gonz\u00e1lez-Vega M, Berhanu TK, Mull A, Garc\u00eda J, Heydemann A. Successful metabolic adaptations leading to the prevention of high fat diet-induced murine cardiac remodeling. Cardiovasc Diabetol. 2015;14:127.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-024-00513-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40779-024-00513-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-024-00513-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:52:55Z","timestamp":1772830375000},"score":1,"resource":{"primary":{"URL":"https:\/\/mmrjournal.biomedcentral.com\/articles\/10.1186\/s40779-024-00513-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1186\/s40779-024-00513-y","relation":{},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"3 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}